![HAYA team in lab](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6417a1ff3c99855167153f76_HAYA-Threapeutics-Our-Approach.webp)
![](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/63f8024866c268769b71dd89_magicpattern-grain-1677197855804.webp)
Long non-coding RNAs
Unexplored Therapeutic Target Landscape
~98% of the human genome is composed of non-protein coding regions. This portion of the genome, known as the 'dark genome,' is dynamically active, generating thousands of therapeutically unexplored long non-coding RNAs (lncRNAs).
![HAYA - Genome graphic](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/645d3ce3da6e53d4b0983e84_HAYA-Genome_2.png)
![HAYA - Genome graphic](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/645d3d21bc959c12bf6d5f6e_Genome_98.png)
LncRNAs - the information processing units of disease-driving cell states
LncRNAs regulate disease-associated gene pathways and proteins in response to the environment, triggering a disease-associated cell state.
![HAYA - Source code diagram for Long non-coding RNAs - 2](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/64517e8446ca2714edfbf138_SourceCode_1.png)
![HAYA - Source code diagram for Long non-coding RNAs - 3](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/64517e83a94f0fb94da50e48_SourceCode_2.png)
![HAYA - Source code diagram for Long non-coding RNAs](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/64517e84dbbb7b2e17e21c65_SourceCode_3.png)
To identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility.
![HAYA - Safe - Effective - Accessible](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/64779e05e8ecdd8060b77e81_Safe_Effective_Accessible.webp)
ViewHAYATM
Identify circulating dark genome biomarkers to inform drug discovery, de-risk clinical trials and develop and deploy diagnostics in clinical practice.
![Graphic for ViewHAYA](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/64594623ac067409f9ad8f17_ViewHAYA.png)
HAYAtlasTM
A unique orthogonal & iterative multi-omic atlas combining public, proprietary and inferred knowledge
- World’s largest and best curated lncRNA database
- Rigorously profiled lncRNAs and dark genome features are disease-, tissue- and cell-specific, and conserved across species
![HAYA Platform - Discover HAYA](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/63c84cba3629e4d5bd4d0f54_HAYA_Platform-DiscoverHAYA.png)
![HAYA Platform - Echo HAYA](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/63c84cde92cc1d022572156e_HAYA_Platform-EchoHAYA.png)
![HAYA Platform - Chem HAYA](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/63c84cedd4cda27937ec81e9_HAYA_Platform-ChemHAYA.png)
![HAYA Platform - View HAYA](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/63c84cf98800707eff007860_HAYA_Platform-ViewHAYA.png)
![HAYA Platform - HAYA Atlas](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/641856c9ebb48662b844d202_HAYAtlas.png)
We are reprograming cell-states to treat rare and common diseases
![Graphic image heart](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6441b031a9a044746f87611b_Website_indication-03.webp)
Wisper
![Graphic image lungs](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6441b031246500011e82f014_Website_indication-04.webp)
![Graphic image TME](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6441b0319b6356495b3ff863_Website_indication-05.webp)
![Graphic image liver](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6441b03174326d5b8f4cb39c_Website_indication-06.webp)
![Graphic image pancreas](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6441b031b57c5681728e198f_Website_indication-07.webp)
![Graphic image kidney](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6441b03141ca6291d29ac46a_Website_indication-08.webp)
Together we can do more
We are passionate and dedicated to our mission. We have a unique and differentiated proprietary platform for reprogramming disease driving cell-states.
Our platform is powerful and versatile, but through partnerships we believe we can do more and help thousands of patients without a current therapeutic option. Partnering with biopharma companies with a given disease or modality expertise is essential to fulfill our mission. Each disease is a unique universe, and each target may require a different approach.
If you are interested in partnering, please:
![HAYA Partnership - Workers in office](https://cdn.prod.website-files.com/6386596aa06a7757ac56b0d0/6451952e665c116ea8949e70_HAYA-Tx-Partnerships.jpg)